Concerning the PAD2 isoform, it has been established that the presence of anti-PAD2 antibodies is correlated with reduced severity of RA and diminished articular progression, as observed radiographically, regardless of the administration of DMARDs [67]. The gene discussed is PADI2; the disease is rheumatoid arthritis.